Skip to main content
Erschienen in: Pediatric Nephrology 7/2009

01.07.2009 | Original Article

Wilms tumor arising in a child with X-linked nephrogenic diabetes insipidus

verfasst von: Reyhan El-Kares, Pierre-Alain Hueber, Miriam Blumenkrantz, Diana Iglesias, Kim Ma, Nada Jabado, Daniel G. Bichet, Paul Goodyer

Erschienen in: Pediatric Nephrology | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Abstract

We report on a child with X-linked nephrogenic diabetes insipidus (NDI) who developed Wilms tumor (WT). Nephrogenic diabetes insipidus is caused by mutations of the arginine vasopressin receptor (AVPR2) or aquaporin-II (AQP2) genes. Wilms tumor is also genetically heterogeneous and is associated with mutations of WT1 (15–20%), WTX (20–30%) and other loci. The boy presented at 5 months with failure to thrive, polyuria, hypernatremia and abdominal mass. Analysis of leukocyte DNA showed a novel missense mutation (Q174H) of the AVPR2 gene, which was not present in his mother. In cells (WitS) isolated from the tumor, WTX mRNA expression and coding sequence were intact. However, we identified a 44-kb homozygous deletion of the WT1 gene spanning exons 4 to 10. The WT1 deletion was not present in leukocyte DNA from the patient or his mother. We also noted strong β-catenin (CTNNB1) expression in the tumor cells and identified a heterozygote missense Ser45Cys mutation of exon 3 of CTNNB1. However, the mutation was absent both in the constitutional DNA of the patient and his mother. The concurrence of WT and NDI has not been previously reported and may be unrelated. Nevertheless, this case nicely illustrates the sequence of events leading to sporadic Wilms tumor.
Literatur
1.
Zurück zum Zitat Zhuang Z, Merino MJ, Vortmeyer AO, Bryant B, Lash AE, Wang C, Deavers MT, Shelton WF, Kapur S, Chandra RS (1997) Identical genetic changes in different histologic components of Wilms’ tumors. J Natl Cancer Inst 89:1148–1152CrossRef Zhuang Z, Merino MJ, Vortmeyer AO, Bryant B, Lash AE, Wang C, Deavers MT, Shelton WF, Kapur S, Chandra RS (1997) Identical genetic changes in different histologic components of Wilms’ tumors. J Natl Cancer Inst 89:1148–1152CrossRef
2.
Zurück zum Zitat Knudson AG Jr, Strong LC (1972) Mutation and cancer: a model for Wilms’ tumor of the kidney. J Natl Cancer Inst 48:313–324PubMed Knudson AG Jr, Strong LC (1972) Mutation and cancer: a model for Wilms’ tumor of the kidney. J Natl Cancer Inst 48:313–324PubMed
3.
Zurück zum Zitat Rose EA, Glaser T, Jones C, Smith CL, Lewis HW, Call KM, Minden M, Champagne E, Bonetta L, Yeger H, Housman DE (1990) Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms’ tumor gene. Cell 60:495–508CrossRef Rose EA, Glaser T, Jones C, Smith CL, Lewis HW, Call KM, Minden M, Champagne E, Bonetta L, Yeger H, Housman DE (1990) Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms’ tumor gene. Cell 60:495–508CrossRef
4.
Zurück zum Zitat Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman D (1991) Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437–447CrossRef Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman D (1991) Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437–447CrossRef
5.
6.
Zurück zum Zitat Maiti S, Alam R, Amos CI, Huff V (2000) Frequent association of beta-catenin and WT1 mutations in Wilms tumors. Cancer Res 60:6288–6292PubMed Maiti S, Alam R, Amos CI, Huff V (2000) Frequent association of beta-catenin and WT1 mutations in Wilms tumors. Cancer Res 60:6288–6292PubMed
7.
Zurück zum Zitat Rivera MN, Kim WJ, Wells J, Driscoll DR, Brannigan BW, Han M, Kim JC, Feinberg AP, Gerald WL, Vargas SO, Chin L, Iafrate AJ, Bell DW, Haber DA (2007) An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science 315:642–645CrossRef Rivera MN, Kim WJ, Wells J, Driscoll DR, Brannigan BW, Han M, Kim JC, Feinberg AP, Gerald WL, Vargas SO, Chin L, Iafrate AJ, Bell DW, Haber DA (2007) An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science 315:642–645CrossRef
8.
Zurück zum Zitat Rosenthal W, Seibold A, Antaramian A, Lonergan M, Arthus MF, Hendy GN, Birnbaumer M, Bichet DG (1992) Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 359:233–235CrossRef Rosenthal W, Seibold A, Antaramian A, Lonergan M, Arthus MF, Hendy GN, Birnbaumer M, Bichet DG (1992) Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 359:233–235CrossRef
9.
Zurück zum Zitat Bichet DG, Birnbaumer M, Lonergan M, Arthus MF, Rosenthal W, Goodyer P, Nivet H, Benoit S, Giampietro P, Simonetti S, Fish A, Whitley CB, Jaeger P, Gertner J, New M, DiBona FJ, Kaplan BS, Robertson GL, Hendy GN, Fujiwara TM, Morgan K (1994) Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet 55:278–286PubMedPubMedCentral Bichet DG, Birnbaumer M, Lonergan M, Arthus MF, Rosenthal W, Goodyer P, Nivet H, Benoit S, Giampietro P, Simonetti S, Fish A, Whitley CB, Jaeger P, Gertner J, New M, DiBona FJ, Kaplan BS, Robertson GL, Hendy GN, Fujiwara TM, Morgan K (1994) Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet 55:278–286PubMedPubMedCentral
10.
Zurück zum Zitat Fujiwara TM, Morgan K, Bichet DG (1996) Molecular analysis of X-linked nephrogenic diabetes insipidus. Eur J Endocrinol 134:675–677CrossRef Fujiwara TM, Morgan K, Bichet DG (1996) Molecular analysis of X-linked nephrogenic diabetes insipidus. Eur J Endocrinol 134:675–677CrossRef
11.
Zurück zum Zitat van den Ouweland AM, Knoop MT, Knoers VV, Markslag PW, Rocchi M, Warren ST, Ropers HH, Fahrenholz F, Monnens LA, van Oost BA (1992) Colocalization of the gene for nephrogenic diabetes insipidus (DIR) and the vasopressin type 2 receptor gene (AVPR2) in the Xq28 region. Genomics 13:1350–1352CrossRef van den Ouweland AM, Knoop MT, Knoers VV, Markslag PW, Rocchi M, Warren ST, Ropers HH, Fahrenholz F, Monnens LA, van Oost BA (1992) Colocalization of the gene for nephrogenic diabetes insipidus (DIR) and the vasopressin type 2 receptor gene (AVPR2) in the Xq28 region. Genomics 13:1350–1352CrossRef
12.
Zurück zum Zitat van Lieburg AF, Verdijk MA, Knoers VV, van Essen AJ, Proesmans W, Mallmann R, Monnens LA, van Oost BA, van Os CH, Deen PM (1994) Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene. Am J Hum Genet 55:648–652PubMedPubMedCentral van Lieburg AF, Verdijk MA, Knoers VV, van Essen AJ, Proesmans W, Mallmann R, Monnens LA, van Oost BA, van Os CH, Deen PM (1994) Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene. Am J Hum Genet 55:648–652PubMedPubMedCentral
13.
Zurück zum Zitat Cowell JK (1980) Consistent chromosome abnormalities associated with mouse bladder epithelial cell lines transformed in vitro. J Natl Cancer Inst 65:955–961PubMed Cowell JK (1980) Consistent chromosome abnormalities associated with mouse bladder epithelial cell lines transformed in vitro. J Natl Cancer Inst 65:955–961PubMed
14.
Zurück zum Zitat Schumacher V, Schneider S, Figge A, Wildhardt G, Harms D, Schmidt D, Weirich A, Ludwig R, Royer-Pokora B (1997) Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology. Proc Natl Acad Sci USA 94:3972–3977CrossRef Schumacher V, Schneider S, Figge A, Wildhardt G, Harms D, Schmidt D, Weirich A, Ludwig R, Royer-Pokora B (1997) Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology. Proc Natl Acad Sci USA 94:3972–3977CrossRef
15.
Zurück zum Zitat Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R (1993) WT-1 is required for early kidney development. Cell 74:679–691CrossRef Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R (1993) WT-1 is required for early kidney development. Cell 74:679–691CrossRef
16.
Zurück zum Zitat Moore AW, McInnes L, Kreidberg J, Hastie ND, Schedl A (1999) YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development 126:1845–1857PubMed Moore AW, McInnes L, Kreidberg J, Hastie ND, Schedl A (1999) YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development 126:1845–1857PubMed
17.
Zurück zum Zitat Rivera MN, Haber DA (2005) Wilms’ tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer 5:699–712CrossRef Rivera MN, Haber DA (2005) Wilms’ tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer 5:699–712CrossRef
18.
Zurück zum Zitat Hanson J, Gorman J, Reese J, Fraizer G (2007) Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1. Front Biosci 12:2279–2290CrossRef Hanson J, Gorman J, Reese J, Fraizer G (2007) Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1. Front Biosci 12:2279–2290CrossRef
19.
Zurück zum Zitat Fukuzawa R, Heathcott RW, More HE, Reeve AE (2007) Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies. J Clin Pathol 60:1013–1016CrossRef Fukuzawa R, Heathcott RW, More HE, Reeve AE (2007) Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies. J Clin Pathol 60:1013–1016CrossRef
20.
Zurück zum Zitat Li CM, Kim CE, Margolin AA, Guo M, Zhu J, Mason JM, Hensle TW, Murty VV, Grundy PE, Fearon ER, D’Agati V, Licht JD, Tycko B (2004) CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms’ tumors. Am J Pathol 165:1943–1953CrossRef Li CM, Kim CE, Margolin AA, Guo M, Zhu J, Mason JM, Hensle TW, Murty VV, Grundy PE, Fearon ER, D’Agati V, Licht JD, Tycko B (2004) CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms’ tumors. Am J Pathol 165:1943–1953CrossRef
21.
Zurück zum Zitat Koesters R, Ridder R, Kopp-Schneider A, Betts D, Adams V, Niggli F, Briner J, von Knebel Doeberitz M (1999) Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms’ tumors. Cancer Res 59:3880–3882PubMed Koesters R, Ridder R, Kopp-Schneider A, Betts D, Adams V, Niggli F, Briner J, von Knebel Doeberitz M (1999) Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms’ tumors. Cancer Res 59:3880–3882PubMed
22.
Zurück zum Zitat Koesters R, von Knebel Doeberitz M (2003) The Wnt signaling pathway in solid childhood tumors. Cancer Lett 198:123–138CrossRef Koesters R, von Knebel Doeberitz M (2003) The Wnt signaling pathway in solid childhood tumors. Cancer Lett 198:123–138CrossRef
23.
Zurück zum Zitat Lolait SJ, O’Carroll AM, McBride OW, Konig M, Morel A, Brownstein MJ (1992) Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357:336–339CrossRef Lolait SJ, O’Carroll AM, McBride OW, Konig M, Morel A, Brownstein MJ (1992) Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357:336–339CrossRef
24.
Zurück zum Zitat Bichet DG (1998) Nephrogenic diabetes insipidus. Am J Med 105:431–442CrossRef Bichet DG (1998) Nephrogenic diabetes insipidus. Am J Med 105:431–442CrossRef
25.
Zurück zum Zitat Arthus MF, Lonergan M, Crumley MJ, Naumova AK, Morin D, De Marco LA, Kaplan BS, Robertson GL, Sasaki S, Morgan K, Bichet DG, Fujiwara TM (2000) Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 11:1044–1054PubMed Arthus MF, Lonergan M, Crumley MJ, Naumova AK, Morin D, De Marco LA, Kaplan BS, Robertson GL, Sasaki S, Morgan K, Bichet DG, Fujiwara TM (2000) Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 11:1044–1054PubMed
26.
Zurück zum Zitat Beckwith JB (1998) Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations. Am J Med Genet 79:268–273CrossRef Beckwith JB (1998) Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations. Am J Med Genet 79:268–273CrossRef
27.
Zurück zum Zitat Hueber PA, Fukuzawa R, El-Kares R, Chu LL, Blumenkrantz M, He S, Anaka MR, Reeve AE, Eccles MR, Jabado N, Iglesias DM, Goodyer PR (2008) PAX3 is expressed in the stromal compartment of the developing kidney and in Wilms Tumors with myogenic phenotype. Pediatr Dev Pathol doi:https://doi.org/10.2350/08-05-0466.1 CrossRef Hueber PA, Fukuzawa R, El-Kares R, Chu LL, Blumenkrantz M, He S, Anaka MR, Reeve AE, Eccles MR, Jabado N, Iglesias DM, Goodyer PR (2008) PAX3 is expressed in the stromal compartment of the developing kidney and in Wilms Tumors with myogenic phenotype. Pediatr Dev Pathol doi:https://​doi.​org/​10.​2350/​08-05-0466.​1 CrossRef
Metadaten
Titel
Wilms tumor arising in a child with X-linked nephrogenic diabetes insipidus
verfasst von
Reyhan El-Kares
Pierre-Alain Hueber
Miriam Blumenkrantz
Diana Iglesias
Kim Ma
Nada Jabado
Daniel G. Bichet
Paul Goodyer
Publikationsdatum
01.07.2009
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 7/2009
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-009-1147-4

Weitere Artikel der Ausgabe 7/2009

Pediatric Nephrology 7/2009 Zur Ausgabe

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

29.05.2024 Reanimation im Kindesalter Nachrichten

Laut einer Studie aus den USA und Kanada scheint es bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.

Bei Amblyopie früher abkleben als bisher empfohlen?

22.05.2024 Fehlsichtigkeit Nachrichten

Bei Amblyopie ist das frühzeitige Abkleben des kontralateralen Auges in den meisten Fällen wohl effektiver als der Therapiestandard mit zunächst mehrmonatigem Brilletragen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.